Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 27826
Event :International Cannabinoid Derived Pharmaceuticals Summit

Dates :Monday December 10th, 2018 - Wednesday December 12th, 2018

Location :Hyatt Regency Boston
1 Avenue de Lafayette
02111 Boston, United States

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.

URLs:
Tickets: https://go.evvnt.com/267417-0?pid=4319
Brochure: https://go.evvnt.com/267417-2?pid=4319

Time: 8:00 am - 6:00 pm

Prices:
Conference Only: GBP 1999.0,
Conference + 2 Workshops: GBP 2897.0

Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamás Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, Le Roy Dowey, Head of Corporate Development, Greenlight Medicines, Vincenzo di Marzo, Canada Excellence Research Chair, Université Laval and Research Director, CNR, Sazzad Hossain, CEO Entourage Biosciences / CSO, Inmed Pharmaceuticals Inc, Allyn Howlett, Professor, Wake Forest University, Gary Hiller, Chief Operations Officer and President, Phytecs, Catherine Jacobson, Director of Clinical Research, Tilray, Zohar Koren, Chief Executive Officer and Founder, SciCann, Shimon Lecht, Chief of Research and Development CannRx, Arnold Lippa, Executive Chairman and Chief Scientific Officer, RespireRx Pharmaceuticals, Jeff Eliot Margolis, Senior Vice President, Chief Financial Officer, Treasurer, Secretary, member of the Board of Directors, RespireRx Pharmaceuticals, Soumyajit Majumdar, Professor of Pharmaceutics and Drug Delivery, University of Mississippi, Brian Murphy, Chief Executive Officer and Chief Medical Officer, Nemus Bioscience, Inc, Richard Purcell, Senior Vive President, RespireRx, Dan Peer, Chair, Tel Aviv University Cancer Biology Research Center; Managing Director, Center for Translational Medicine, Jutta Roth, Chief Scientific Officer, Oxford Cannabinoid Technologies, Andrea Small- Howard, Chief Scientific Officer, GB Sciences, Adi Zulloff-Shani, Chief Technology Officer, Therapix

Location

Map and directions
Conference address :
Hyatt Regency Boston
1 Avenue de Lafayette
02111 Boston
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

International Cannabinoid Derived Pharmaceuticals Summit Pharmacy
--
Everyone
-- -- --
English

Other

For more information on International Cannabinoid Derived Pharmaceuticals Summit, plsase contactr Hanson Wade

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event